LTF and COVID-19: The decrease in lactoferrin and IgA in COVID-19 patients suggests impairment of the immunoprotective mechanisms of the mucosal barrier; lactoferrin may play an essential role in the pathophysiology of severe cases, since these patients might be vulnerable to secondary airway infection.